Please enable JavaScript to continue using this application.

Compare $ABEO vs $ZSQR | Chartloom

Compare

$ABEO vs $ZSQR

Abeona Therapeutics Inc · Z Squared Inc (Delaware)

ABEO

Abeona Therapeutics Inc

ZSQR

Z Squared Inc (Delaware)

Compare $ABEO vs $ZSQR

Comparing Abeona Therapeutics Inc and Z Squared Inc (Delaware)

ABEOAbeona Therapeutics Inc

ZSQRZ Squared Inc (Delaware)

ABEOAbeona Therapeutics Inc

Market cap

$282M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.20x

Rev growth (TTM)

6280.0%

YTD performance

-7.0%

52W performance

-10.8%

FCF yield

-29.0%

ZSQRZ Squared Inc (Delaware)

Market cap

$298M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

961.0%

YTD performance

-62.8%

52W performance

-62.8%

FCF yield

-1.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ABEO

ZSQR

Detailed metrics comparison

ABEO

Abeona Therapeutics Inc

ZSQR

Z Squared Inc (Delaware)

Market Cap

ABEO$282M

ZSQR$298M

Enterprise Value

ABEO$240M

ZSQR$283M

Price

ABEO$4.94

ZSQR$5.66

P/E Ratio

ABEON/A

ZSQRN/A

P/S Ratio

ABEO11.03x

ZSQR106.71x

EV/Sales

ABEO9.42x

ZSQR101.17x

EV/EBITDA

ABEO3.95x

ZSQR0.00x

P/B Ratio

ABEO2.25x

ZSQR1.36x

P/FCF Ratio

ABEON/A

ZSQRN/A

EV/FCF

ABEO-2.95x

ZSQR-69.99x

PEG Ratio

ABEON/A

ZSQRN/A

Forward P/E (NTM)

ABEON/A

ZSQRN/A

Forward P/S (NTM)

ABEO3.20x

ZSQRN/A

Revenue (TTM)

ABEO$26M

ZSQR$3M

Revenue Growth (YoY)

ABEO6280.0%

ZSQR961.0%

Forward Rev Growth

ABEO131.0%

ZSQR0.0%

Gross Margin (TTM)

ABEO67.1%

ZSQR-24.6%

Operating Margin (TTM)

ABEO0.0%

ZSQR0.0%

EBITDA Margin (TTM)

ABEO-316.6%

ZSQR-712.5%

Net Margin (TTM)

ABEO-246.4%

ZSQR-785.1%

FCF Margin (TTM)

ABEO-319.5%

ZSQR-144.6%

Net Income (TTM)

ABEO$-63M

ZSQR$-22M

FCF (TTM)

ABEO$-82M

ZSQR$-4M

EPS (TTM)

ABEO-$1.10

ZSQR-$0.44

ROE (TTM)

ABEO-4169.0%

ZSQR-5059.0%

ROA (TTM)

ABEO-3036.0%

ZSQR-4757.0%

ROIC (TTM)

ABEO-3719.0%

ZSQR-5038.0%

Cash

ABEO$56M

ZSQR$15M

Debt

ABEO$15M

ZSQR$0

Net Cash/Debt

ABEO$41M

ZSQR$15M

Current Ratio (TTM)

ABEO6.63x

ZSQR7.66x

Quick Ratio (TTM)

ABEO6.32x

ZSQR7.64x

Debt/Equity (TTM)

ABEO0.12x

ZSQR0.02x

Debt/Assets (TTM)

ABEO0.0%

ZSQR0.0%

Interest Coverage (TTM)

ABEON/A

ZSQRN/A

Net Debt/EBITDA (TTM)

ABEO0.00x

ZSQR0.00x

Beta

ABEO1.45

ZSQRN/A

52W Performance

ABEO-10.8%

ZSQR-62.8%

YTD Performance

ABEO-7.0%

ZSQR-62.8%

% from 52W High

ABEO-35.4%

ZSQR-69.9%

% from 52W Low

ABEO23.5%

ZSQR168.2%

Asset Turnover (TTM)

ABEO0.13x

ZSQR0.06x

FCF Yield (TTM)

ABEO-29.0%

ZSQR-1.4%

Earnings Yield (TTM)

ABEO-22.3%

ZSQR-7.4%

Dividend Yield (TTM)

ABEON/A

ZSQRN/A

Rule of 40

ABEO5,960.5

ZSQR816.4

EV/GP/RG

ABEO0.04

ZSQRN/A

Ticker research

View ABEO research View ZSQR research

Metric	ABEO Abeona Therapeutics Inc	ZSQR Z Squared Inc (Delaware)
Market & Valuation
Market Cap	$282M	$298M
Enterprise Value	$240M	$283M
Price	$4.94	$5.66
P/E Ratio	N/A	N/A
P/S Ratio	11.03x	106.71x
EV/Sales	9.42x	101.17x
EV/EBITDA	3.95x	0.00x
P/B Ratio	2.25x	1.36x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.95x	-69.99x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.20x	N/A
Revenue & Growth
Revenue (TTM)	$26M	$3M
Revenue Growth (YoY)	6280.0%	961.0%
Forward Rev Growth	131.0%	0.0%
Profitability
Gross Margin (TTM)	67.1%	-24.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-316.6%	-712.5%
Net Margin (TTM)	-246.4%	-785.1%
FCF Margin (TTM)	-319.5%	-144.6%
Net Income (TTM)	$-63M	$-22M
FCF (TTM)	$-82M	$-4M
EPS (TTM)	-$1.10	-$0.44
ROE (TTM)	-4169.0%	-5059.0%
ROA (TTM)	-3036.0%	-4757.0%
ROIC (TTM)	-3719.0%	-5038.0%
Financial Health
Cash	$56M	$15M
Debt	$15M	$0
Net Cash/Debt	$41M	$15M
Current Ratio (TTM)	6.63x	7.66x
Quick Ratio (TTM)	6.32x	7.64x
Debt/Equity (TTM)	0.12x	0.02x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.45	N/A
52W Performance	-10.8%	-62.8%
YTD Performance	-7.0%	-62.8%
% from 52W High	-35.4%	-69.9%
% from 52W Low	23.5%	168.2%
Efficiency & Yields
Asset Turnover (TTM)	0.13x	0.06x
FCF Yield (TTM)	-29.0%	-1.4%
Earnings Yield (TTM)	-22.3%	-7.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5,960.5	816.4
EV/GP/RG	0.04	N/A
Ticker research	View ABEO research	View ZSQR research

Valuation

P/S Ratio

ABEO

11.03x

ZSQR

106.71x

EV/FCF

ZSQR

-69.99x

ABEO

-2.95x

Growth & revenue

Revenue Growth TTM

ABEO

6280.0%

ZSQR

961.0%

Forward Revenue Growth

ABEO

131.0%

ZSQR

0.0%

Profitability & performance

Gross Margin

ABEO

67.1%

ZSQR

-24.6%

ROE

ABEO

-4169.0%

ZSQR

-5059.0%

FCF Yield %

ZSQR

-1.4%

ABEO

-29.0%

52-Week Performance

ABEO

-10.8%

ZSQR

-62.8%

Detailed metrics comparison

ABEO

Abeona Therapeutics Inc

ZSQR

Z Squared Inc (Delaware)

Market Cap

ABEO$282M

ZSQR$298M

Enterprise Value

ABEO$240M

ZSQR$283M

Price

ABEO$4.94

ZSQR$5.66

P/E Ratio

ABEON/A

ZSQRN/A

P/S Ratio

ABEO11.03x

ZSQR106.71x

EV/Sales

ABEO9.42x

ZSQR101.17x

EV/EBITDA

ABEO3.95x

ZSQR0.00x

P/B Ratio

ABEO2.25x

ZSQR1.36x

P/FCF Ratio

ABEON/A

ZSQRN/A

EV/FCF

ABEO-2.95x

ZSQR-69.99x

PEG Ratio

ABEON/A

ZSQRN/A

Forward P/E (NTM)

ABEON/A

ZSQRN/A

Forward P/S (NTM)

ABEO3.20x

ZSQRN/A

Revenue (TTM)

ABEO$26M

ZSQR$3M

Revenue Growth (YoY)

ABEO6280.0%

ZSQR961.0%

Forward Rev Growth

ABEO131.0%

ZSQR0.0%

Gross Margin (TTM)

ABEO67.1%

ZSQR-24.6%

Operating Margin (TTM)

ABEO0.0%

ZSQR0.0%

EBITDA Margin (TTM)

ABEO-316.6%

ZSQR-712.5%

Net Margin (TTM)

ABEO-246.4%

ZSQR-785.1%

FCF Margin (TTM)

ABEO-319.5%

ZSQR-144.6%

Net Income (TTM)

ABEO$-63M

ZSQR$-22M

FCF (TTM)

ABEO$-82M

ZSQR$-4M

EPS (TTM)

ABEO-$1.10

ZSQR-$0.44

ROE (TTM)

ABEO-4169.0%

ZSQR-5059.0%

ROA (TTM)

ABEO-3036.0%

ZSQR-4757.0%

ROIC (TTM)

ABEO-3719.0%

ZSQR-5038.0%

Cash

ABEO$56M

ZSQR$15M

Debt

ABEO$15M

ZSQR$0

Net Cash/Debt

ABEO$41M

ZSQR$15M

Current Ratio (TTM)

ABEO6.63x

ZSQR7.66x

Quick Ratio (TTM)

ABEO6.32x

ZSQR7.64x

Debt/Equity (TTM)

ABEO0.12x

ZSQR0.02x

Debt/Assets (TTM)

ABEO0.0%

ZSQR0.0%

Interest Coverage (TTM)

ABEON/A

ZSQRN/A

Net Debt/EBITDA (TTM)

ABEO0.00x

ZSQR0.00x

Beta

ABEO1.45

ZSQRN/A

52W Performance

ABEO-10.8%

ZSQR-62.8%

YTD Performance

ABEO-7.0%

ZSQR-62.8%

% from 52W High

ABEO-35.4%

ZSQR-69.9%

% from 52W Low

ABEO23.5%

ZSQR168.2%

Asset Turnover (TTM)

ABEO0.13x

ZSQR0.06x

FCF Yield (TTM)

ABEO-29.0%

ZSQR-1.4%

Earnings Yield (TTM)

ABEO-22.3%

ZSQR-7.4%

Dividend Yield (TTM)

ABEON/A

ZSQRN/A

Rule of 40

ABEO5,960.5

ZSQR816.4

EV/GP/RG

ABEO0.04

ZSQRN/A

Ticker research

View ABEO research View ZSQR research

Metric	ABEO Abeona Therapeutics Inc	ZSQR Z Squared Inc (Delaware)
Market & Valuation
Market Cap	$282M	$298M
Enterprise Value	$240M	$283M
Price	$4.94	$5.66
P/E Ratio	N/A	N/A
P/S Ratio	11.03x	106.71x
EV/Sales	9.42x	101.17x
EV/EBITDA	3.95x	0.00x
P/B Ratio	2.25x	1.36x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.95x	-69.99x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.20x	N/A
Revenue & Growth
Revenue (TTM)	$26M	$3M
Revenue Growth (YoY)	6280.0%	961.0%
Forward Rev Growth	131.0%	0.0%
Profitability
Gross Margin (TTM)	67.1%	-24.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-316.6%	-712.5%
Net Margin (TTM)	-246.4%	-785.1%
FCF Margin (TTM)	-319.5%	-144.6%
Net Income (TTM)	$-63M	$-22M
FCF (TTM)	$-82M	$-4M
EPS (TTM)	-$1.10	-$0.44
ROE (TTM)	-4169.0%	-5059.0%
ROA (TTM)	-3036.0%	-4757.0%
ROIC (TTM)	-3719.0%	-5038.0%
Financial Health
Cash	$56M	$15M
Debt	$15M	$0
Net Cash/Debt	$41M	$15M
Current Ratio (TTM)	6.63x	7.66x
Quick Ratio (TTM)	6.32x	7.64x
Debt/Equity (TTM)	0.12x	0.02x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.45	N/A
52W Performance	-10.8%	-62.8%
YTD Performance	-7.0%	-62.8%
% from 52W High	-35.4%	-69.9%
% from 52W Low	23.5%	168.2%
Efficiency & Yields
Asset Turnover (TTM)	0.13x	0.06x
FCF Yield (TTM)	-29.0%	-1.4%
Earnings Yield (TTM)	-22.3%	-7.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5,960.5	816.4
EV/GP/RG	0.04	N/A
Ticker research	View ABEO research	View ZSQR research